These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


83 related items for PubMed ID: 2297773

  • 1. Rate of buthionine sulfoximine entry into brain and xenotransplanted human gliomas.
    Fekete I, Griffith OW, Schlageter KE, Bigner DD, Friedman HS, Groothuis DR.
    Cancer Res; 1990 Feb 15; 50(4):1251-6. PubMed ID: 2297773
    [Abstract] [Full Text] [Related]

  • 2. The effect of an amino acid-lowering diet on the rate of melphalan entry into brain and xenotransplanted glioma.
    Groothuis DR, Lippitz BE, Fekete I, Schlageter KE, Molnar P, Colvin OM, Roe CR, Bigner DD, Friedman HS.
    Cancer Res; 1992 Oct 15; 52(20):5590-6. PubMed ID: 1394182
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study.
    Shapiro WR, Voorhies RM, Hiesiger EM, Sher PB, Basler GA, Lipschutz LE.
    Cancer Res; 1988 Feb 01; 48(3):694-701. PubMed ID: 3335031
    [Abstract] [Full Text] [Related]

  • 4. Enhanced melphalan cytotoxicity following buthionine sulfoximine-mediated glutathione depletion in a human medulloblastoma xenograft in athymic mice.
    Skapek SX, Colvin OM, Griffith OW, Elion GB, Bigner DD, Friedman HS.
    Cancer Res; 1988 May 15; 48(10):2764-7. PubMed ID: 3359437
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of DL-buthionine-S,R-sulfoximine on the growth of EMT6 and RIF mouse tumors.
    Miller AC, Henderson BW.
    J Natl Cancer Inst; 1986 Aug 15; 77(2):505-10. PubMed ID: 3461211
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
    Kramer RA, Greene K, Ahmad S, Vistica DT.
    Cancer Res; 1987 Mar 15; 47(6):1593-7. PubMed ID: 3815359
    [Abstract] [Full Text] [Related]

  • 12. Lack of enhanced antitumor efficacy for L-buthionine sulfoximine in combination with carmustine, cyclophosphamide, doxorubicin or melphalan in mice.
    Soble MJ, Dorr RT.
    Anticancer Res; 1988 Mar 15; 8(1):17-22. PubMed ID: 3358633
    [Abstract] [Full Text] [Related]

  • 13. Establishment of a melphalan-resistant rhabdomyosarcoma xenograft with cross-resistance to vincristine and enhanced sensitivity following buthionine sulfoximine-mediated glutathione depletion.
    Rosenberg MC, Colvin OM, Griffith OW, Bigner SH, Elion GB, Horton JK, Lilley E, Bigner DD, Friedman HS.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):6917-22. PubMed ID: 2582434
    [Abstract] [Full Text] [Related]

  • 14. Concurrent measurements of blood flow and transcapillary transport in xenotransplanted human gliomas in immunosuppressed rats.
    Vriesendorp FJ, Peagram C, Bigner DD, Groothuis DR.
    J Natl Cancer Inst; 1987 Jul 15; 79(1):123-30. PubMed ID: 3474439
    [Abstract] [Full Text] [Related]

  • 15. Buthionine sulfoximine-mediated depletion of glutathione in intracranial human glioma-derived xenografts.
    Skapek SX, Colvin OM, Griffith OW, Groothuis DR, Colapinto EV, Lee Y, Hilton J, Elion GB, Bigner DD, Friedman HS.
    Biochem Pharmacol; 1988 Nov 15; 37(22):4313-7. PubMed ID: 3196356
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
    Ali-Osman F, Antoun G, Wang H, Rajagopal S, Gagucas E.
    Mol Pharmacol; 1996 Jun 15; 49(6):1012-20. PubMed ID: 8649339
    [Abstract] [Full Text] [Related]

  • 20. Sensitive enzymatic cycling assay for glutathione: measurements of glutathione content and its modulation by buthionine sulfoximine in vivo and in vitro in human colon cancer.
    Berger SJ, Gosky D, Zborowska E, Willson JK, Berger NA.
    Cancer Res; 1994 Aug 01; 54(15):4077-83. PubMed ID: 8033140
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.